HER2

Affibody® Research Reagent Catalog number Size Price

Anti-HER2, unconjugated

10.0817.01.0001

100 µg

 170

Anti-HER2, unconjugated

10.0817.01.0005

500 µg

 465

Anti-HER2, biotin conjugated

10.0817.02.0001

100 µg

 465

Anti-HER2, fluorescein conjugated

10.0817.03.0001

100 µg

 465

Anti-HER2, agarose immobilized

10.0817.04.0002

200 µl

 550

Anti-HER2, IP kit

10.0817.04.9002

200 µl

 615

Anti-HER2, HRP conjugated

10.0817.05.0002

200 µl

 465

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Interim Report January to March 2020 (May 15, 2020)
  • Interim Report January to June 2020 (August 21, 2020)
  • Interim Report January to September 2020 (November 13, 2020)
  • Year End Report 2020 (February 2021)